Latest HBIO reports update at 2024-05-07: 2024-Q12023-Q42023-Q1
Harvard Bioscience logo
Harvard Bioscience HBIO
$ 3.56 -3.26%

Harvard Bioscience Financial Ratios 2011-2024 | HBIO

Annual Financial Ratios Harvard Bioscience

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-55.0 -11.5 -756.4 -23.0 -24.1 -41.8 -188.8 -23.0 -5.2 71.2 -75.0 45.6 23.0

P/S

1.7 1.0 1.8 1.8 1.0 1.0 1.6 0.9 0.9 1.5 1.3 1.0 0.8

EPS

-0.1 -0.2 -0.0 -0.2 -0.1 -0.1 -0.0 -0.1 -0.6 0.1 -0.1 0.1 0.1

EV (Enterprise Value)

248 M 178 M 289 M 251 M 188 M 200 M 187 M 129 M 136 M 194 M 153 M 117 M 101 M

EBITDA per Share

0.08 -0.13 0.1 0.153 0.201 0.175 0.0674 0.0464 0.0564 0.293 0.207 0.216 0.327

EV/EBITDA

70.9 36.9 20.9 27.4 72.3 67.7 59.1 18.6 21.7 16.1 9.3

PEG

0.63 0.5 -23.49 -0.32 -0.72 -0.12 2.23 0.3 0.01 -0.32 0.43 -1.18 -0.29

P/B

2.6 1.5 2.6 2.3 1.4 1.5 2.0 1.4 1.3 1.8 1.5 1.0 0.9

P/CF

13.4 94.9 172.6 21.9 16.6 65.0 1276.1 25.4 -43.9 71.4 57.7 17.3 17.0

ROE %

-4.67 -13.18 -0.35 -10.19 -5.74 -3.53 -1.07 -5.97 -24.54 2.47 -1.94 2.27 3.99

ROA %

-2.49 -6.55 -0.18 -5.00 -2.84 -1.73 -0.79 -4.00 -15.84 1.73 -1.35 1.78 3.01

ROCE %

2.59 -9.60 2.48 0.16 1.32 0.67 -0.11 -1.22 -0.92 5.80 3.09 2.81 5.59

Current Ratio

2.1 2.0 2.1 2.5 2.1 2.7 3.4 3.1 2.6 3.2 3.8 6.0 6.0

DSO

53.3 62.1 60.8 63.5 65.0 74.3 73.3 69.6 71.9 70.1 61.3 62.3 58.9

DIO

202.2 187.7 177.5 184.4 155.3 159.0 143.6 129.8 136.1 126.3 100.2 110.3 113.1

DPO

47.4 39.5 38.8 49.5 37.6 46.6 36.3 40.3 53.5 38.7 29.7 29.1 30.9

Operating Cycle

255.5 249.8 238.3 247.9 220.3 233.3 216.8 199.4 208.0 196.5 161.5 172.6 172.0

Cash Conversion Cycle

208.1 210.3 199.5 198.5 182.8 186.6 180.5 159.1 154.5 157.7 131.7 143.6 141.2

All numbers in USD currency

Quarterly Financial Ratios Harvard Bioscience

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.11 - -0.03 -0.02 0.01 - -0.08 0.06 -0.17 - - -0.01 -0.02 - -0.03 -0.04 -0.12 0.02 -0.07 -0.01 -0.06 0.08 -0.01 -0.04 -0.11 0.03 -0.01 -0.01 -0.03 -0.04 -0.05 -0.02 -0.02 -0.51 -0.02 0.01 -0.04 - 0.02 0.03 0.03 -0.02 -0.03 -0.01 - 0.04 -0.01 0.02 0.02 0.03 - 0.05 0.06

EBITDA per Share

-0.04 - 0.01 0.05 0.05 - -0.05 0.13 -0.15 - 49.2 37.9 0.01 - 42 40 -0.07 0.04 - 0.03 0.01 0.05 0.06 0.02 -0.02 0.01 0.02 0.01 - -0.03 0.01 - - - 0.01 0.03 -0.02 0.07 0.07 0.07 0.07 -0.03 0.05 0.05 0.06 0.07 0.07 0.11 0.08 0.05 0.04 0.11 0.08

ROE %

-11.46 -2.13 -6.86 -9.92 -5.48 -10.60 -10.82 -6.31 -9.97 -1.61 -3.04 -4.25 -5.79 -9.38 -8.71 -10.48 -8.73 -5.74 -2.95 -0.05 -1.52 -3.53 -5.76 -5.96 -4.66 -1.07 -4.13 -5.89 -6.40 -5.97 -26.23 -25.05 -23.61 -24.54 -2.47 -0.71 -0.09 2.78 2.00 0.30 -0.95 -1.92 0.04 0.95 1.87 2.27 1.90 2.05 2.74 0.77 0.03 1.43 -

ROA %

-5.98 -1.15 -1.15 -0.26 -3.93 -8.71 -8.82 -4.57 -4.84 -0.82 -1.52 -2.11 -2.86 -4.60 -4.27 -5.16 -4.30 -2.84 -1.48 -0.04 -0.76 -1.73 -2.52 -2.75 -2.23 -0.79 -2.93 -4.07 -4.38 -4.00 -17.05 -16.23 -15.28 -15.86 -1.60 -0.42 0.04 1.96 1.41 0.22 -0.66 -1.34 0.12 0.74 1.45 1.78 1.46 1.58 2.08 0.58 0.02 1.08 -

ROCE %

-4.77 2.15 -3.07 -7.04 -2.94 -8.86 -8.14 -2.20 -7.29 0.48 0.71 0.24 0.89 -3.31 -1.31 -3.22 -3.66 0.46 0.57 3.31 2.57 1.19 -0.45 -2.01 -1.88 -0.78 -2.80 -3.45 -4.28 -4.15 -2.45 -2.32 -1.03 -2.21 -0.13 2.36 4.05 7.36 4.13 3.07 1.96 1.55 4.60 5.27 6.94 7.51 6.92 6.04 6.30 1.45 0.23 2.64 -

Current Ratio

2.1 2.1 2.1 2.1 2.0 2.0 - - 1.9 2.1 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 3.8 3.8 3.8 3.8 3.0 3.0 3.0 3.0 2.8 2.8 2.8 2.8 3.4 3.4 3.4 3.4 3.3 3.3 3.6 3.3 4.6 4.6 4.6 4.6 4.1 4.1 4.1 -

DSO

58.5 - 57.4 55.0 52.4 - - 31.7 66.8 - 55.0 53.9 58.9 - 67.4 69.5 73.8 61.0 68.9 63.9 68.2 57.8 68.4 62.1 59.4 56.4 65.2 64.4 73.5 54.4 57.5 55.0 56.3 56.4 62.2 55.6 59.7 48.5 57.9 54.6 50.8 45.5 50.3 48.5 49.4 46.4 50.2 46.0 47.4 47.4 52.1 25.3 -

DIO

228.8 - 222.7 199.9 209.1 - - 104.2 203.8 - 173.2 168.3 177.4 - 192.7 214.9 187.4 146.5 161.8 147.7 178.6 151.4 178.6 141.6 141.8 144.7 166.8 155.5 197.3 127.2 136.7 125.9 137.7 132.0 145.6 125.8 136.9 113.5 133.8 127.6 112.8 91.1 112.2 110.9 110.7 109.1 114.7 108.8 109.7 104.9 114.3 57.7 -

DPO

54.3 - 47.1 40.4 48.8 - - 22.6 40.3 - 44.8 49.4 48.9 - 51.7 57.6 47.8 35.5 39.2 35.8 48.1 44.4 52.4 41.5 39.8 37.9 43.7 40.7 56.9 39.5 42.5 39.1 48.8 51.9 57.2 49.5 48.1 34.8 41.0 39.1 34.1 27.0 31.5 31.1 30.9 28.8 30.2 28.7 29.4 28.6 31.2 15.8 -

Operating Cycle

287.3 - 280.0 254.8 261.5 - - 135.9 270.6 - 228.1 222.2 236.3 - 260.1 284.5 261.3 207.5 230.8 211.6 246.8 209.3 247.0 203.7 201.2 201.1 232.0 219.9 270.8 181.6 194.2 180.9 194.0 188.4 207.8 181.4 196.6 162.1 191.6 182.3 163.7 136.6 162.5 159.3 160.1 155.5 164.8 154.7 157.1 152.3 166.4 83.0 -

Cash Conversion Cycle

233.0 - 232.9 214.5 212.8 - - 113.3 230.3 - 183.3 172.8 187.4 - 208.4 226.8 213.4 172.1 191.6 175.8 198.7 164.8 194.6 162.2 161.4 163.2 188.4 179.2 213.9 142.1 151.7 141.8 145.3 136.6 150.6 132.0 148.4 127.2 150.6 143.1 129.6 109.5 131.0 128.2 129.2 126.7 134.6 126.1 127.7 123.6 135.2 67.3 -

All numbers in USD currency